A Multicenter, Randomized Trial of the Inhibitory Effect of NSAIDs for APR in Primary Osteoporosis Patients Administered Zoledronic Acid

Trial Profile

A Multicenter, Randomized Trial of the Inhibitory Effect of NSAIDs for APR in Primary Osteoporosis Patients Administered Zoledronic Acid

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs Zoledronic acid (Primary) ; Loxoprofen
  • Indications Osteoporosis
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Sep 2017 Planned End Date changed from 7 Oct 2017 to 7 Nov 2017.
    • 14 Mar 2017 New trial record
    • 11 Mar 2017 Planned End Date changed from 30 Sep 2017 to 7 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top